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Purpose: To compare optic nerve head (ONH) measurements in glaucomatous eyes with 
paracentral visual field (VF) loss to eyes with peripheral VF loss and controls.
Methods: Open-angle glaucoma (OAG) patients with early paracentral VF loss or isolated 
peripheral VF loss as well as control subjects underwent ONH imaging with swept-source 
optical coherence tomography (OCT) and retinal nerve fiber layer (RNFL) imaging with 
spectral-domain OCT. Minimum rim width at Bruch’s membrane opening (BMO-MRW), 
lamina cribrosa depth (LCD), and RNFL thickness were compared among the glaucoma and 
control groups with one-way analysis of variance, Kruskal–Wallis test, and multiple regres-
sion analysis.
Results: Twenty-nine eyes from 29 OAG patients (15 early paracentral and 14 isolated peripheral 
VF loss) and 20 eyes of 20 control subjects were included. The early paracentral and isolated 
peripheral VF loss groups had similar VF mean deviation (MD) (-5.3±2.7 dB and -3.7±3.0 dB, 
p=0.15, respectively). Global BMO-MRW was lower in OAG eyes than in controls (193.8±40.0 
vs 322.7±62.2 μm, p,0.001), but similar between eyes with early paracentral VF loss and 
those with isolated peripheral VF loss (187.6±43.4 vs 200.6±36.3 μm; p.0.99). In contrast, 
the minimal BMO-MRW was lower in eyes with early paracentral loss (69.0±33.6 μm) than 
in eyes with isolated peripheral loss (107.7±40.2 μm; p=0.03) or control eyes (200.1±40.8 μm; 
p,0.001). Average and thinnest RNFL thickness did not differ between OAG groups (p=0.61 
and 0.19, respectively). Horizontal and vertical LCD did not differ among the OAG groups and 
controls (p=0.80 and 0.82, respectively). Multivariable linear regression analysis among OAG 
cases confirmed the association between lower minimal BMO-MRW and early paracentral VF 
loss (β=-38.3 μm; 95% confidence interval, -69.8 to -6.8 μm; p=0.02) after adjusting for age, 
gender, MD, and disc size.
Conclusion: Thin minimal BMO-MRW may represent a new structural biomarker associated 
with early glaucomatous paracentral VF loss.
Keywords: paracentral loss, BMO-MRW, open angle glaucoma, optic nerve damage, swept-
source OCT
Introduction
Glaucoma is a heterogeneous group of disorders characterized by progressive 
degeneration of retinal ganglion cells and their axons, leading to cupping of the optic 
nerve head (ONH) with various patterns of visual field (VF) loss.1,2 Functionally, 
patients with paracentral VF loss can have significant decline in quality of life3 and 
delayed reaction, while patients with peripheral VF loss increase visual scanning to 
compensate when driving.4
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Clinically, the optic nerve in patients with paracentral 
VF loss tends to show localized damage, consisting of disc 
hemorrhage,5 focal narrowing of the rim,6 and acquired optic 
nerve pits.7 The structural damage associated with paracentral 
VF loss has been quantified with spectral-domain optical 
coherence tomography (SD-OCT), which showed local-
ized loss of retinal nerve fiber layer (RNFL) thickness and 
thinning of macular inner retinal layer compared to eyes with 
peripheral VF loss.8
Swept-source optical coherence tomography (SS-OCT) 
is a novel imaging technology, with higher scanning speed, 
longer wavelength, and improved signal detection than SD-
OCT, achieving better simultaneous imaging of both super-
ficial and deep tissue structures.9 These features improve 
visualization and quantification of localized and subtle 
glaucomatous changes of the ONH.
Novel quantitative parameters have emerged with 
improved imaging technologies. The minimum rim width 
at Bruch’s membrane opening (BMO-MRW), defined as 
the minimal distance between the termination of BMO 
and the internal limiting membrane within each radial scan 
of the ONH,10 provides a surrogate measure for the number 
of axons entering the ONH.11 Associations between BMO-
MRW and VF sensitivity were demonstrated to be stronger 
than other RNFL and ONH parameters,12 particularly in the 
later stages of glaucoma.13 Another new parameter is the 
lamina cribrosa depth (LCD), which describes the posterior 
displacement of the lamina cribrosa (LC) and is defined as the 
average distance between a reference line connecting the two 
termination points of Bruch’s membrane at the ONH and the 
anterior LC surface.14 Greater LCD was found in glaucoma 
patients compared to control subjects, and this parameter 
may vary in different optic disc phenotypes of open-angle 
glaucoma (OAG).15,16
In this study, we used SS-OCT to measure and compare 
the prelaminar and laminar ONH tissues in eyes with OAG 
and control eyes, aiming to identify novel quantitative 
parameters (biomarkers) associated with glaucomatous 
paracentral VF loss.
Subjects and methods
This was a prospective, cross-sectional study, approved by 
the Institutional Review Boards of Massachusetts Eye and 
Ear (MEE) in accordance with Health Insurance Portability 
and Accountability Act regulations, and it adhered to the 
tenets of the Declaration of Helsinki. Each study subject 
provided written informed consent.
Description of the study sample
Adult patients of European and African descent aged between 
30 and 90 years were recruited for this study. Some subjects 
were part of a prior study by this group comparing SS-OCT 
and EDI-OCT in measuring quantitative parameters of 
the ONH.17
Definition of OAG and control groups
Patients with OAG were recruited from the Glaucoma Con-
sultation Service of MEE. These patients had best-corrected 
visual acuity of at least 20/40, open angles on gonioscopy, 
a clinical diagnosis of OAG with reproducible VF loss, and 
corresponding glaucomatous optic nerve damage. Only 
patients with reliable Humphrey visual field (HVF) tests 
(fixation loss #33%, false-positive rate #20% and false-
negative rate #20%) were included. Patients with previous 
penetrating glaucoma surgeries (trabeculectomies and glau-
coma drainage devices), optic disc torsion more than 15°, or 
tilt ratio .1.3 (maximum to minimum optic disc diameter) 
were excluded.18,19
For each OAG patient, the HVF (Swedish Interactive 
Threshold Algorithm standard, 24-2) dated within 1 year 
of the imaging date was reviewed independently by two 
glaucoma specialists (LRP and LQS) and classified into two 
categories, as described previously20 and outlined briefly 
here. Each defect comprised of a cluster of three or more 
contiguous points on the pattern deviation plot with reti-
nal sensitivity depression worse than -5 dB at each point 
(Figure 1). Early paracentral loss was defined as a VF defect 
located within the central 10°, either in the superior or in 
the inferior hemifield, with or without involvement of the 
peripheral region in the same hemifield. An isolated periph-
eral loss involved the Bjerrum areas, nasal step, or temporal 
wedge zones in the superior and/or inferior hemifield, without 
affecting the central 10°.
Control subjects were recruited from the Comprehen-
sive Ophthalmology and Cataract Consultation Service 
of MEE and were age-matched to OAG cases by decade. 
The control eyes had best corrected visual acuity of at least 
20/40, intraocular pressure (IOP) lower than 22 mmHg, and 
normal optic nerves (defined as cup-to-disc ratio #0.6 in 
both eyes and cup-to-disc ratio asymmetry ,0.2). Patients 
with family history of glaucoma, any evidence or suspicion 
of glaucoma (such as abnormality on peripapillary RNFL 
profile on SD-OCT), ocular hypertension, or significant 
retinal pathology were excluded. Control subjects did not 
undergo VF testing.
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image acquisition
The eyes of all subjects were dilated to obtain images with the 
best quality. A commercially available SS-OCT (Deep Range 
Imaging OCT-1; Topcon, Tokyo, Japan) was used to image 
both eyes of all subjects. The device uses a wavelength-sweep-
ing laser, with a center wavelength of 1,050 nm, and acquires 
100,000 A-scans/sec with 8 μm axial resolution.21,22 The 
imaging protocol included a radial B-scan pattern, consisting 
of 12 sequential sections, and a five-line cross B-scan pat-
tern, consisting of five sequential vertical and five sequential 
horizontal sections spaced 250 μm apart, all centered on the 
optic disc. Each image has 32 image frames averaged. At the 
same visit, peripapillary RNFL thickness was obtained with 
SD-OCT (Spectralis; Heidelberg Engineering, Heidelberg, 
Germany). Digital disc photographs (Visucam Pro NM; Carl 
Zeiss, Meditec, Dublin, CA, USA) were taken in subjects who 
did not have photos within 12 months of OCT imaging.
imaging analysis
Two observers (EVT and DL) independently performed mea-
surements of quantitative prelaminar and laminar parameters 
using customized ImageJ (ImageJ, US National Institutes 
of Health, Bethesda, MD, USA) plugins. The BMO-MRW 
was measured within the ONH from radial B-scans. As pre-
viously described,17 the internal limiting membrane was 
automatically delineated, and BMO was manually identified. 
Subsequently, the minimum distance from BMO to internal 
limiting membrane was automatically identified and calcu-
lated on each side of the 12 radial scans (total of 24 measure-
ments per eye). The global BMO-MRW was the average 
of 24 measurements; the minimal BMO-MRW (Figure 2) 
was the lowest value among these 24 measurements of 
BMO-MRW per eye; the minimal sector BMO-MRW was 
the lowest value among the 6 sectors, which were obtained 
Figure 1 Examples of patterns of VF loss on HVFs (Swedish Interactive Threshold Algorithm 24-2) as defined in this study.
Notes: Pattern deviation plots from left eyes are shown. numeric values are in the top row and probability plots are in the bottom row. examples of early paracentral loss 
with superior paracentral region outlined in black (left) and isolated peripheral loss with superior nasal step zone outlined in black (right) are included.
Abbreviations: VF, visual field; HVF, Humphrey visual field.
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Figure 2 Quantitative assessment of the Onh with ss-OCT in an eye with early paracentral loss and in an eye with isolated peripheral loss.
Notes: Top row shows an eye with early paracentral loss: disc photograph (left), minimal BMO-MrW =34.8 μm (center left), lCDh =449.1 μm (center), lCDV =478.4 μm 
(center right), and peripapillary RNFL thickness profile (right). The corresponding HVF is shown in Figure 1 (left). Bottom row shows an eye with isolated peripheral loss: disc 
photograph (left), minimal BMO-MrW =139.5 μm (center left), lCDh =397.6 μm (center), lCDV =454.9 μm (center right), and peripapillary RNFL thickness profile (right). 
The corresponding hVF is shown in Figure 1 (right). arrows in different colors and patterns indicate location and orientation of scans. Minimal BMO-MrW indicated by red 
circle and red line (center left), lCDh and lCDV as averages of blue lines (center and center right) were measured on images taken with ss-OCT. The red line delineates the 
anterior lamina cribrosa surface and the green line connects termination points of Bruch’s membrane (center and center right). rnFl thickness was measured with sD-OCT 
as shown in the rnFl sector maps (right). The average rnFl is the value in the center (g, global). The minimal rnFl was the lowest value in the sectors (ns, superonasal; 
Ts, superotemporal; T, temporal; n, nasal; ni, inferonasal and Ti, inferotemporal).
Abbreviations: BMO-MrW, minimum rim width at Bruch’s membrane opening; lCDh, horizontal lamina cribrosa depth; lCDV, vertical lamina cribrosa depth; Onh, 
optic nerve head; RNFL, retinal nerve fiber layer; HVF, Humphrey visual field; SS-OCT, swept-source optical coherence tomography; SD-OCT, spectral-domain optical 
coherence tomography.
by averaging the BMO-MRW measurements of all scans 
in each sector (Figure S1). In addition, scaled BMO-MRW 
normalized by disc circumference was calculated according 
to a published method.23
The LCD was measured in one horizontal and in one 
vertical scan, which were selected from all scans at 90° and 
180° for the best visualization of the anterior LC surface and 
best centration.17 After the manual delineation of the anterior 
surface of LC, a reference line connecting BMO was drawn. 
An ImageJ plugin calculated the perpendicular distance from 
the reference line to the anterior surface of LC every 100 μm 
along the reference line (Figure 2) and generated the mean 
measurement.
Average RNFL thickness and thinnest clock-hour sector 
of RNFL thickness were extracted from SD-OCT RNFL 
profile plot.
statistical analysis
Only one eye per subject was included in the analysis. If both 
eyes were eligible, the right eye was used for control subjects 
and eyes with matching VF mean deviation (MD) were used 
for glaucoma patients. Statistical analysis was performed with 
the Statistical Package for the Social Sciences (SPSS, v.17, 
Chicago, IL, USA). The normality of continuous variables 
was assessed with the Kolmogorov–Smirnov test. Quantita-
tive variables were expressed as mean ± standard deviation 
(SD) and qualitative variables as percentages. Comparison 
between groups was performed with one-way analysis of vari-
ance for normally distributed variables and Kruskal–Wallis 
test for nonnormally distributed variables. For quantitative 
parameters, interobserver agreement was assessed using 
intraclass correlation coefficient. Statistical significance was 
assumed at p#0.05 level, and Bonferroni correction was 
applied to correct α error for multiple comparisons. Among 
OAG cases, a multivariate linear regression model was built 
with minimal BMO-MRW as the dependent variable and the 
type of VF loss as the main predictor. The model was adjusted 
for age, gender, VF MD, and BMO circumference.
Results
Forty-nine subjects (29 patients with OAG and 20 controls) 
were included in this study. The mean ± standard deviation 
age was 65.7±9.0 years for OAG patients and 66.6±7.1 years 
for control subjects (p=0.72). In OAG subgroups, patients 
with early paracentral loss were younger than patients with 
isolated peripheral loss (61.9±6.3 vs 69.8±9.9 years, p=0.03, 
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Table 1). Ninety-three percent of OAG patients and 95.0% of 
control subjects were White (p=0.96); no significant differ-
ence in ethnicity was found among the OAG subgroups. The 
mean IOP measured by Goldmann applanation tonometry 
on the day of imaging was 13.8±2.7 mmHg in OAG eyes, 
and 14.4±2.2 mmHg in controls (p=0.41); no difference 
was found among OAG subgroups (p.0.99). The untreated 
maximum IOP was available in 48 (97.9%) of 49 subjects; 
it was 19.8±3.4 mmHg in OAG eyes and 15.4±1.8 mmHg in 
controls (p=0.0001), with no difference between glaucoma 
subgroups (p=0.84). The HVF MD was -5.3±2.7 dB in the 
early paracentral loss group and -3.7±3.0 dB in the isolated 
peripheral loss group (p=0.15).
Interobserver agreement was very good for all measured 
parameters: intraclass correlation coefficient was 0.98, 0.94, 
0.93, and 0.96 for global BMO-MRW, minimal BMO-
MRW, horizontal LCD, and vertical LCD, respectively.17 
All radial images were of adequate quality for BMO-MRW 
measurements. In 36.2% of the radial images, the LC was 
not visible and the five-line images were used instead for 
LCD measurements.
Mean global BMO-MRW was lower in glaucomatous 
eyes than in control eyes (193.8±40.0 vs 322.7±62.2 μm, 
p=0.0001) and similar between eyes with early paracentral 
loss and those with isolated peripheral loss (187.6±43.4 vs 
200.6±36.3 μm; p.0.99). Similar findings were obtained 
with scaled global BMO-MRW (Table 2). The minimal 
sector BMO-MRW was lowest in eyes with early para-
central loss (109.3±38.2 μm), which differed from the 
control group (229.1±44.1 μm, p,0.001) but not from 
the eyes with isolated peripheral loss (139.3±39.5 μm, 
p=0.17). This was also observed with scaled minimal 
sector BMO-MRW.
The minimal BMO-MRW was 200.1±40.8 μm in control 
eyes and 87.7±41.2 μm in OAG eyes (p=0.0001). Eyes with 
early paracentral loss (Figure 2) had significantly lower 
minimal BMO-MRW than eyes with isolated peripheral 
loss (69.0±33.6 vs 107.7±40.2 μm, p=0.03). Similarly, low 
scaled minimal BMO-MRW distinguished eyes with para-
central loss from eyes with isolated peripheral loss (p=0.04) 
and control eyes (p=0.0001, Table 2). The location of the 
minimal BMO-MRW was the temporal quadrant in 90% 
of the control eyes. In eyes with early paracentral loss, the 
minimal BMO-MRW was located in the inferior quadrant 
(including inferior-temporal and inferior-nasal) (80%), 
temporal quadrant (13.3%), or superior-temporal quadrant 
(6.7%) in that order; 86.7% of all minimal BMO-MRW 
locations corresponded to the VF defect location. In eyes 
with isolated peripheral loss, the minimal BMO-MRW was 
located in the inferior quadrant (57.1%), temporal quadrant 
(21.4%), superior-temporal quadrant (14.3%), and nasal 
quadrant (7.1%); 35.7% of all locations corresponded to the 
hemifield with more severe VF defect (p=0.008 compared 
to correspondence in early paracentral VF loss).
The mean horizontal LCD was 433.5±94.6 μm in control 
eyes and 440.8±109.9 μm in OAG eyes (p=0.80), while the 
mean vertical LCD was 448.8±105.2 μm in controls eyes and 
455.7±94.3 μm in OAG eyes (p=0.82). Neither parameter 
was significantly different among the OAG subgroups 
(p.0.19 for all, Table 2).
The average RNFL thickness measured with SD-OCT 
was 96.6±10.4 μm in control eyes and 73.1±12.3 μm in 
OAG eyes (p=0.0001, Table 2); eyes with early paracentral 
loss were not significantly different than eyes with isolated 
peripheral loss (p=0.61); and neither was the thinnest RNFL 
thickness (p=0.19).
Table 1 Clinical characteristics among the studied groups
Clinical 
characteristics
Control eyes 
(N=20)
Early paracentral 
loss eyes
(N=I5)
Isolated peripheral 
loss eyes
(N=I4)
p-value
Control vs early 
paracentral loss
p-value
Control 
vs isolated 
peripheral loss
p-value
Early 
paracentral 
vs isolated 
peripheral loss
age (years) 66.6±7.1 61.9±6.3 69.8±9.9 0.26 0.71 0.03*
gender, female (%) 60.0% 80.0% 64.3% 0.28 .0.99 0.43
ethnicity, Caucasian (%) 95.0% 93.3% 92.9% .0.99 .0.99 .0.99
lOP (mmhg) 14.4±2.2 14.0±2.5 13.6±3.0 .0.99 .0.99 .0.99
Maximum lOP (mmhg)a 15.4±1.8 20.3±3.2 19.2±3.6 ,0.001* 0.002* 0.84
VF MD (dB) n/a -5.3±2.7 -3.7±3.0 n/a n/a 0.15
VF PsD (dB) n/a 5.8±3.3 3.3±1.7 n/a n/a 0.02*
Notes: Values are expressed as mean ± standard deviation unless otherwise specified. *Statistically significant difference, p,0.05. aKnown untreated maximum iOP was 
available for all control eyes and 28 of 29 glaucoma eyes. 
Abbreviations: IOP, intraocular pressure; VF MD, visual field mean deviation; VF PSD, visual field pattern standard deviation; N/A, not available.
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The association between minimal BMO-MRW and 
paracentral VF loss was further assessed in multiple 
regression analysis of OAG groups; eyes with isolated 
peripheral loss served as the reference group. Low minimal 
BMO-MRW was significantly associated with early para-
central loss (β=-38.3 μm; 95% confidence interval, -69.8 
to -6.8 μm; p=0.02, Table 3), after adjusting for age 
(p=0.86), gender (p=0.08), VF MD (p=0.21), and BMO 
circumference (p=0.02). A previous report suggest that 
linear conversion of MD is required to correlate structure 
with function, as MD is derived from logarithmic scale.11 In 
our study, linearization of VF MD did not change the out-
come of the multiple regression model, and thus the effect 
of early paracentral loss on minimal BMO-MRW remained 
significant (β=-36.1 μm; 95% confidence interval, -66.5 
to -5.7 μm; p=0.02), after adjusting for age (p=0.74), gender 
(p=0.07), and linearized VF MD (p=0.17). There is an asso-
ciation between lower minimal BMO-MRW and lower BMO 
circumference (p=0.01).
Discussion
Glaucomatous optic nerve damage manifests in different 
patterns of VF loss, sometimes involving the central vision 
early during the course of the disease. In this study, we 
focused on eyes with early paracentral loss (ie, VF loss within 
the central 10° with or without peripheral loss in the same 
hemifield) instead of isolated paracentral loss,5 as glaucoma-
tous paracentral scotomas are usually accompanied by some 
degrees of peripheral loss in the same hemifield. This was 
demonstrated by a previous study, which computationally 
identified VF loss patterns from a database comprised of 
13,231 HVFs from the same practice.24 Furthermore, systemic 
and genetic factors associated with paracentral scotoma have 
been identified using similar VF criteria.20,25 In this prospec-
tive study, with the aid of SS-OCT, we identified prelaminar 
pathology, in particular thin minimal BMO-MRW to be more 
common in patients with early paracentral VF loss than in 
those with isolated peripheral VF loss. Using multivariate 
regression analysis, we demonstrated that the association 
between thin minimal BMO-MRW and paracentral loss was 
independent of VF severity.
Our study supports the use of minimal BMO-MRW as a 
quantitative parameter in glaucoma evaluation. The param-
eter BMO-MRW, unlike the clinically used rim area, which 
is based on clinical disc margin, relies on BMO. It provides 
a good surrogate for the number of axons entering the ONH,11 
and may have better sensitivity and specificity for glaucoma 
Table 2 Quantitative parameters among the studied group
ONH parameters (μm) Control  
eyes  
(N=20)
Early  
paracentral 
loss eyes  
(N=15)
Isolated 
peripheral 
loss eyes 
(N=14)
p-value 
Control 
vs early 
paracentral loss
p-value
Control 
vs isolated 
peripheral loss
p-value
Paracentral 
vs isolated 
peripheral loss
ss-OCT global BMO-MrW 322.7±62.2 187.6±43.4 200.6±36.3 ,0.001* ,0.001* .0.99
ss-OCT scaled global BMO-MrW 308.3±70.8 187.3±40.2 207.9±60.6 ,0.001* ,0.001* .0.99
ss-OCT minimal BMO-MrW 200.1±40.8 69.0±33.6 107.7±40.2 ,0.001* ,0.001* 0.03*
ss-OCT scaled minimal BMO-MrW 191.4±45.0 69.5±35.6 114.0±55.53 ,0.001* ,0.001* 0.04*
ss-OCT minimal sector BMO-MrW 229.1±44.1 109.3±38.2 139.2±39.5 ,0.001* ,0.001* 0.17
ss-OCT scaled minimal sector BMO-MrW 219.5±51.6 110.3±41.4 145.7±57.9 ,0.001* ,0.001* 0.20
ss-OCT lCDh 433.5±94.6 465.4±104.5 414.5±113.2 .0.99 .0.99 0.57
ss-OCT lCDV 448.8±105.2 487.9±94.6 418.4±82.3 0.72 .0.99 0.19
sD-OCT average rnFlT 96.6±10.4 70.4±9.7 75.9±14.3 ,0.001* ,0.001* 0.61
sD-OCT thinnest rnFlT 66.7±8.0 47.1±8.9 53.6±10.7 ,0.001* 0.001* 0.19
Notes: Values are expressed as mean ± standard deviation. *Statistically significant difference, p,0.05. 
Abbreviations: ss-OCT, swept source optical coherence tomography; BMO-MrW, minimum rim width at Bruch’s membrane opening; lCDh, horizontal lamina cribrosa 
depth; LCDV, vertical lamina cribrosa depth; ONH, optic nerve head; SD-OCT, spectral domain optical coherence tomography; RNFLT, retina nerve fiber layer thickness.
Table 3 Multivariate linear regression for the measurement of 
minimal BMO-MrW
Variable β 95% CI p-value
Lower 
bound
Upper 
bound
C
ov
ar
ia
te
s age -0.1 -1.8 1.5 0.86
gender (reference: 
male)
-28.2 -59.7 -3.2 0.08
Visual field MD -3.2 -8.2 1.9 0.21
BMO circumference 0.03 0.005 0.05 0.02*
early paracentral VF 
loss (reference: isolated 
peripheral VF loss)
-38.3 -69.8 -6.8 0.02*
Note: *Statistically significant association, p,0.05. 
Abbreviations: MD, mean deviation; BMO, Bruch’s membrane opening; BMO-
MRW, minimum rim width at Bruch’s membrane opening; VF, visual field; CI, 
confidence interval.
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detection than RNFL-based parameters.26,27 In this study, we 
found that global BMO-MRW was significantly affected 
in glaucomatous eyes compared to that in controls; this is 
consistent with the literature.26 Furthermore, OAG eyes with 
early paracentral VF loss had significantly thinner minimal 
BMO-MRW compared to eyes with peripheral VF loss, 
whereas RNFL thickness parameters (thinnest and aver-
age), global BMO-MRW (average and scaled), and minimal 
sector BMO-MRW (average and scaled) were comparable 
between these two groups. Minimal BMO-MRW may be a 
unique quantitative ONH biomarker associated with early 
paracentral VF loss; since the BMO-MRW is measured 
within the optic nerve, it may be more likely to reflect local 
ONH changes than peripapillary RNFL thickness, as the 
latter is measured on average 1.7 mm away from the center 
of the optic nerve.28 In addition, minimal BMO-MRW rep-
resents the focal ON damage corresponding to a discrete 
area near fixation on the VF, whereas global BMO-MRW 
and sector BMO-MRW cannot capture the focal thinning 
(Figure S2).
The multivariate analysis also showed an association 
between lower minimal BMO-MRW and lower BMO 
circumference, suggesting that focal thinning of the neu-
roretinal rim may be more common in smaller discs with 
glaucoma. Although this observation differs from a report 
on global BMO-MRW and healthy eyes, where BMO-
MRW is lower in eyes with macrodiscs than microdiscs,29 
it is consistent with previous characterization of different 
glaucomatous optic disc phenotypes.30 A disc phenotype 
associated with paracentral VF loss (focal glaucomatous) 
was found to have smaller disc size than other phenotypes 
(senile sclerotic and generalized cup enlargement), which 
rarely manifest in VF loss near fixation. It is likely that 
qualitative description of different glaucomatous optic disc 
appearances can be quantified with novel imaging param-
eters; minimal BMO-MRW serves as a parameter for focal 
glaucomatous phenotype.
In contrast to prelaminar pathology, this cross-sectional 
study of treated OAG patients without incisional surgery 
versus controls did not find a difference in LCD, among 
controls or OAG eyes with different VF loss patterns. 
Previous studies described increased LCD, attributable to 
posterior displacement, thinning, or remodeling of the LC, 
as a component of glaucomatous optic neuropathy.14,31–33 
Our method of measuring LCD was similar to a recent 
publication using SS-OCT32 but differed from those using 
EDI-OCT, which averaged LCD obtained from multiple 
locations of the ONH.14,31 It is also likely that lower or 
higher IOP and trans-LC pressure gradient may play an 
important role in LCD.15,34,35 Hence, in this study, where 
OAG patients on ocular hypotensive treatment and control 
subjects had similar IOP on the day of imaging, the differ-
ence in LCD was not significant. It is also possible that a 
larger sample size is needed to detect a difference between 
glaucoma and control subjects.14,32 Additional studies 
demonstrated thinner LC in patients with glaucoma.36 We 
were not able to visualize the posterior surface of the LC 
in a consistent manner and therefore did not include LC 
thickness measurements.
Our findings suggest that glaucomatous ONH changes 
associated with early paracentral VF loss may occur 
primarily as focal lesions in the neuronal tissue, anterior 
to the LC. There may be localized ischemia affecting the 
papillomacular bundle of the neuronal tissue, causing severe 
thinning of the BMO-MRW and paracentral VF loss. This 
is consistent with previous reports that patients with para-
central loss are more likely to have vascular dysregulation, 
leading to local ischemia, such as Raynaud’s syndrome.5 
In addition, this is supported by clinical examination of the 
ONH, which shows localized changes such as disc hemor-
rhage5 or acquired pit7 associated with paracentral VF loss. 
Additional research is needed to confirm our findings and 
to optimize the detection strategy for patients at risk for 
paracentral VF loss.
This study has several limitations. First, it had a relatively 
small sample size, and the findings need to be confirmed in 
other studies. Second, the study population was relatively 
homogeneous, consisting predominantly of white subjects; 
ONH characteristics might be different in a glaucomatous 
population of other ethnicities, although a recent study did not 
find significant difference in BMO-MRW thickness between 
normal eyes of African descent and European descent.37 Third, 
the measurement of BMO-MRW was performed manually by 
experienced observers with the aid of customized software. 
While this method was found to be reliable and reproducible in 
our previous study,17 existing automated segmentation software 
for BMO-MRW may require manual correction and further 
refinement. Finally, given the cross-sectional design of this 
study, a cause and effect relation could not be established.
Conclusion
Our study showed that glaucomatous optic nerve damage 
can manifest in the prelaminar tissue as focal thinning of 
BMO-MRW; thin minimal BMO-MRW may represent a 
new structural biomarker associated with glaucomatous 
paracentral scotoma.
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Supplementary materials
Figure S1 Diagram showing scans included in each sector for calculating sector BMO-MrW in a right eye.
Notes: n: 10, 11, 12, 1, 2, 3, 4; sn: 5, 6, 7; sT: 8, 9, 10; T: 11, 12, 1, 2, 3; iT: 4, 5, 6; in: 7, 8, 9. similarly, the corresponding scans were used for calculating sector BMO-
MrW in left eyes.
Abbreviations: BMO-MrW, minimum rim width at Bruch’s membrane opening; n, nasal; sn, superonasal; sT, superotemporal; T, temporal; iT, inferotemporal; 
in, inferonasal.
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Figure S2 (Continued)
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Figure S2 example of a left eye with early paracentral loss.
Notes: The corresponding visual field test is shown in Figure 1 left side. The minimal BMO-MRW is 34.8 μm and the minimal sector BMO-MrW, as an average over three 
adjacent scans, is thicker at 92.4 μm. (A) Minimal BMO-MrW (34.8 μm) is in the inferotemporal sector (red arrow) on scan 6. (B) BMO-MrW in the inferotemporal sector 
(red arrowheads) is 109.3 μm on scan 5. (C) BMO-MrW in the inferotemporal sector (red arrowheads) is 133.0 μm on scan 4.
Abbreviation: BMO-MrW, minimum rim width at Bruch’s membrane opening.
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